Skip Navigation

Advertise|Press|Contact|FAQ|CWConnect

Bookmark/Print/Share

Home » Clinical Trials » Therapeutic Areas
Therapeutic Areas: Nephrology | Urology | Family Medicine
Disease Category: Erectile Dysfunction
Location: United States, FL

Clinical Trial Details

Overview

Research Study Summary

Erectile Dysfunction

Purpose

This is a Phase 3 randomized, double-blind placebo controlled study to evaluate the safety and efficacy a study drug in treatment of ED in patients with diabetes. The study consists of 16 weeks with 5 office visits. You will be compensated for your time and travel upon completion of study.

Patient Inclusion Criteria

  • Male 18 and older
  • Have diabetes I or II, use of antidiabetic medications
  • 6 month history of mild to sever ED
  • Must be in a monogamous, heterosexual relationship for at least 3 months.

Patient Inclusion Criteria

  • Previous or current antiandrogen therapy
  • Untreated hypogonadism or testosterone <325
  • Uncontrolled hypertension
  • MI, Stroke, within the past 6 months
  • Positive STD, HIV, or HVC
  • Participation in another investicagational study within 30 days

To Learn more
Phase

3

Gender

Male

Age

18 and up

Overall Status

Recruiting

Duration

16 Weeks

Facility Type

N/A

Contact

Lisa Dunham, Recruiting
Renstar Medical Research
104 SE 1ST Ave #B
Ocala, FL 34471
Phone: 352-629-5800

View Map

Research Center Information: Renstar Medical Research

CW ID: 144754

Date Last Changed: July 25, 2013


DISCLAIMER: This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials.